Fundraising Fox

Preveta

Techstars '20

Redondo Beach, US · Founded 2018 · Delaware corporation · 22 employees on LinkedIn · 6 known investors

Preveta provides care navigation technology to healthcare providers, designed to improve care coordination and help patients access support within the healthcare system.

Also known as Preveta Corp

Founders & leadership

Preveta was founded in 2018 by Victor Lee.

VLVictor Lee
Victor LeeinCEO & Co-Founder
SLShirley Lee
Shirley LeeinFounder/ VP Clinical Strategy

Board

AFAdrian Fenty
Adrian Fentyin𝕏Board directorManaging General Partner at MaC Venture Capital

Investors · 6

Reported raises · per SEC filings

Form D private placements

$6.3M disclosed across 1 of 2 rounds · 2021–2022

$6.3MraisedJan 2023 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Victor LeeExecutive Officer, Director
  • Adrian FentyDirector
  • Shirley LeeDirector
Offering amount
$6.3M
Amount sold
$6.3M
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Preveta develops an AI-enabled care navigation and coordination platform for oncology and specialty care practices. The software ingests data from electronic health record and practice management systems, layers on the clinical protocols and treatment pathways used by a practice, and surfaces a longitudinal view of every patient across the care journey — identifying who is progressing, who is overdue for an intervention, who is eligible for second- and third-line therapies, and who currently qualifies for a clinical trial. Alongside this dashboard, which the company markets as an "AI command center," Preveta deploys AI agents intended to act on identified care gaps and reduce manual follow-up by clinical staff.

The company's stated mission is to give healthcare providers data-driven insights that eliminate care coordination breakdowns so patients can access the support needed to navigate the healthcare system. At the time of its 2021 seed announcement, Preveta focused on urology, chronic disease and cancer — particularly prostate and bladder cancers — and described plans to expand into additional areas such as gastrointestinal care. The platform launched in early 2020.

Founding story

Preveta was founded in 2018 by Victor Lee, his wife Shirley Lee, and Steven Hu. Victor Lee has said the idea followed his experience helping a friend navigate Stage 4 ovarian cancer, where reaching the right doctor and specialist referrals took three months, motivating a platform focused on earlier detection and intervention.

Business model

Preveta sells software to healthcare provider organizations — oncology, urology and other specialty practices — that integrates with their EHR and practice management systems. Marketing materials position the product as increasing the number of patients kept in treatment and increasing practice revenue.

Software sold to clinical practices; a third-party profile classifies the company's revenue as recurring software revenue.

Traction

As of the April 2021 seed announcement, the platform served about 2,000 patients across six major medical groups. The company names partner practices including Anne Arundel Urology and Rio Grande Urology, and lists EHR integrations.

Latest developments

The company currently markets an AI command center for oncology and specialty care that combines a real-time patient view with AI agents for closing care gaps, and describes itself as building an AI clinical workforce for these specialties.

Full profile — market position, technology, go-to-market, geography, history

Market position

Operates in the healthtech/SaaS care-coordination segment; comparable companies cited include Prevounce Health, Outcomes4Me, VieCure and VivorCare.

Preveta positions itself as combining a real-time, whole-panel view of patients with AI agents that take action on identified gaps, rather than limiting AI to clinical documentation.

Technology

The platform unifies clinical data from EHR and practice management systems, applies codified clinical protocols and treatment pathways through algorithms, and uses AI agents plus system alerts and workflows to prompt and execute follow-up actions by care navigation teams.

Go-to-market

Direct sales to practices via demo requests, with proceeds of the 2021 seed round earmarked for sales, marketing and brand building; the site highlights partner practices and physician testimonials.

Oncology and specialty care clinics and physician groups, including urology practices such as Anne Arundel Urology and Rio Grande Urology.

Geography

United States; the company is associated with Redondo Beach and Los Angeles, California, with team members based in Los Angeles, Baltimore and Kansas City.

History

Founded in 2018, Preveta launched its platform in early 2020 and participated in a Techstars accelerator. In April 2021 it announced a $2 million seed round led by MaC Venture Capital and TSVC, and in January 2023 dot.LA reported a $6.2 million raise disclosed in an SEC filing. The product has since been repositioned as an AI command center with AI agents for oncology and specialty care.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
EmployeesFeb 20247 employees
Medical groups servedApr 20216 medical groups
Patients on platformApr 20212,000 patients

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 1

by search overlap

Companies competing with Preveta for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 4

launches, deals, and filings
Jan 2023
Preveta Corp raises $6.2M per SEC filing

Redondo Beach-based medical care coordination platform Preveta Corp raised $6.2 million in funding, according to an SEC filing reported in dot.LA's weekly funding roundup.

$6.2M source ↗

Apr 2021
Preveta raises $2M seed round led by MaC Venture Capital and TSVC

Preveta announced $2 million in seed funding led by MaC Venture Capital and TSVC, to be used for sales, marketing and brand building. The raise came roughly three months after the company took part in the Techstars LA accelerator program.

$2M source ↗

Jan 2020
Participation in Techstars accelerator

Preveta took part in a Techstars accelerator program (listed as Techstars: Space, 2020; separately described as the Techstars LA accelerator attended roughly three months before the April 2021 seed announcement).

source ↗

Jan 2020
Platform launched

Preveta's care coordination platform launched in early 2020.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities · 1

corporate structure
PrevetaDelaware

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Preveta do?
Preveta is a US health-tech company whose AI care navigation platform helps oncology and specialty clinics close care gaps.
Who founded Preveta?
Preveta was founded by Victor Lee in 2018.
Who are Preveta's investors?
Preveta's investors include Bullpen Capital, MaC Venture Capital, Navigate Ventures, Techstars, TMV, TSVC.
How much funding has Preveta raised?
Preveta has disclosed $6.3M raised across 1 of its 2 known rounds.
Where is Preveta headquartered?
Preveta is headquartered in Redondo Beach, US.